The Ig Heavy Chain Protein but Not Its Message Controls Early B Cell Development
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Whole-Genome Microarray Detects Deletions and Loss of Heterozygosity of Chromosome 3 Occurring Exclusively in Metastasizing Uveal Melanoma
Anatomy and Pathology Whole-Genome Microarray Detects Deletions and Loss of Heterozygosity of Chromosome 3 Occurring Exclusively in Metastasizing Uveal Melanoma Sarah L. Lake,1 Sarah E. Coupland,1 Azzam F. G. Taktak,2 and Bertil E. Damato3 PURPOSE. To detect deletions and loss of heterozygosity of disease is fatal in 92% of patients within 2 years of diagnosis. chromosome 3 in a rare subset of fatal, disomy 3 uveal mela- Clinical and histopathologic risk factors for UM metastasis noma (UM), undetectable by fluorescence in situ hybridization include large basal tumor diameter (LBD), ciliary body involve- (FISH). ment, epithelioid cytomorphology, extracellular matrix peri- ϩ ETHODS odic acid-Schiff-positive (PAS ) loops, and high mitotic M . Multiplex ligation-dependent probe amplification 3,4 5 (MLPA) with the P027 UM assay was performed on formalin- count. Prescher et al. showed that a nonrandom genetic fixed, paraffin-embedded (FFPE) whole tumor sections from 19 change, monosomy 3, correlates strongly with metastatic death, and the correlation has since been confirmed by several disomy 3 metastasizing UMs. Whole-genome microarray analy- 3,6–10 ses using a single-nucleotide polymorphism microarray (aSNP) groups. Consequently, fluorescence in situ hybridization were performed on frozen tissue samples from four fatal dis- (FISH) detection of chromosome 3 using a centromeric probe omy 3 metastasizing UMs and three disomy 3 tumors with Ͼ5 became routine practice for UM prognostication; however, 5% years’ metastasis-free survival. to 20% of disomy 3 UM patients unexpectedly develop metas- tases.11 Attempts have therefore been made to identify the RESULTS. Two metastasizing UMs that had been classified as minimal region(s) of deletion on chromosome 3.12–15 Despite disomy 3 by FISH analysis of a small tumor sample were found these studies, little progress has been made in defining the key on MLPA analysis to show monosomy 3. -
In Silico Analysis of Single Nucleotide Polymorphism (Snps) in Human RAG1 and RAG2 Genes of Severe Combined Immunodeficiency
Central JSM Bioinformatics, Genomics and Proteomics Bringing Excellence in Open Access Research Article *Corresponding author Mona Shams Aldeen S. Ali, Department of Applied Bioinformatics, Africa City of Technology, Khartoum, In silico Analysis of Single Sudan, Tel: 249121784688; Email: Submitted: 26 May 2016 Nucleotide Polymorphism Accepted: 17 June 2016 Published: 27 June 2016 (SNPs) in Human RAG1 and Copyright © 2016 Ali et al. RAG2 Genes of Severe OPEN ACCESS Keywords Combined Immunodeficiency • Severe combined immunodeficiency • Primary immunodeficiency Mona Shams Aldeen S. Ali1,2*, Tomador Siddig MZ1,2, Rehab A. • T lymphocytes Elhadi1,2, Muhammad Rahama Yousof2, Siddig Eltyeb Yousif • Recombinase activating genes • non synonymous Single Nucleotide Polymorphisms Abdallah1, Maiada Mohamed Yousif Ahmed2, Nosiba Yahia Mohamed Hassen1, Sulum Omer Masoud Mohamed1, Marwa Mohamed Osman2, and Mohamed A. Hassan2 1Department of Rheumatology, Omdurman Teaching Hospital, Sudan 2Department of Applied Bioinformatics, Africa City of Technology, Sudan Abstract Severe combined immunodeficiency is an inherited Primary immunodeficiency PID, which is characterized by the absence or dysfunction of T lymphocytes. Defects in RAG1 and RAG2 are known to cause a T-B-NK+ form of SCID. Recombinase activating genes RAG1 and RAG2 (OMIM 179615,179616 respectively) are expressed exclusively in lymphocytes and mediate the creation of double-strand. DNA breaks at the sites of recombination and in signal sequences during T− and B− cell receptor gene rearrangement. This study was focused on the effect of nonsynonymous single nucleotide polymorphisms in the function and structure of RAG1& RAG2 genes using In silico analysis. Only nsSNPs and 3’UTR SNPs were selected for computational analysis. Predictions of deleterious nsSNPs were performed by bioinformatics software. -
Autoaggressive T Cells in the Periphery RAG2
Cutting Edge: CD40-Induced Expression of Recombination Activating Gene (RAG) 1 and RAG2: A Mechanism for the Generation of Autoaggressive T Cells in the Periphery This information is current as of September 25, 2021. Gisela M. Vaitaitis, Michelle Poulin, Richard J. Sanderson, Kathryn Haskins and David H. Wagner, Jr. J Immunol 2003; 170:3455-3459; ; doi: 10.4049/jimmunol.170.7.3455 http://www.jimmunol.org/content/170/7/3455 Downloaded from References This article cites 24 articles, 12 of which you can access for free at: http://www.jimmunol.org/content/170/7/3455.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 25, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2003 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. THE JOURNAL OF IMMUNOLOGY CUTTING EDGE Cutting Edge: CD40-Induced Expression of Recombination Activating Gene (RAG) 1 and RAG2: A Mechanism for the Generation of Autoaggressive T Cells in the Periphery1 Gisela M. -
Regulating Antigen-Receptor Gene Assembly
REVIEWS REGULATING ANTIGEN-RECEPTOR GENE ASSEMBLY Mark S. Schlissel The genes encoding antigen receptors are unique because of their high diversity and their assembly in developing lymphocytes from gene segments through a series of site-specific DNA recombination reactions known as V(D)J rearrangement. This review focuses on our understanding of how recombination of immunoglobulin and T-cell receptor gene segments is tightly regulated despite being catalysed by a common lymphoid recombinase, which recognizes a widely distributed conserved recombination signal sequence. Probable mechanisms involve precise expression of the lymphoid-restricted recombination-activating genes RAG1 and RAG2, and developmentally regulated epigenetic alterations in template accessibility, which are targeted by transcriptional regulatory elements and involve chromatin-modifying enzymes. RECOMBINATION SIGNAL It has been nearly 25 years since Tonegawa and col- V(D)J recombination: levels of regulation 1 SEQUENCES leagues shattered one of the basic assumptions of V(D)J recombination has three types of regulation — (RSSs). Short, conserved DNA molecular biology, the inviolate structure of the lineage specificity, order within a lineage and allelic sequences that flank all genome, and in so doing solved a fundamental puzzle exclusion. Transcriptional regulation limits the expres- rearranging gene segments and serve as the recognition elements in immunology — the generation of antigen-receptor sion of RAG proteins to the progenitor stages of B- for the recombinase machinery. -
Allelic Exclusion of the Immunoglobulin Heavy Chain Locus Is Independent of Its Nuclear Localization in Mature B Cells Sjoerd J
Published online 7 June 2013 Nucleic Acids Research, 2013, Vol. 41, No. 14 6905–6916 doi:10.1093/nar/gkt491 Allelic exclusion of the immunoglobulin heavy chain locus is independent of its nuclear localization in mature B cells Sjoerd J. B. Holwerda1, Harmen J. G. van de Werken1, Claudia Ribeiro de Almeida2, Ingrid M. Bergen2, Marjolein J. W. de Bruijn2, Marjon J. A. M. Verstegen1, Marieke Simonis1, Erik Splinter1, Patrick J. Wijchers1, Rudi W. Hendriks2,* and Wouter de Laat1,* 1Hubrecht Institute-KNAW & University Medical Center Utrecht, Utrecht 3584 CT, The Netherlands and 2Department of Pulmonary Medicine, Erasmus MC Rotterdam, Rotterdam, Box 2040, 3000 CA, The Netherlands Received April 7, 2013; Revised May 6, 2013; Accepted May 11, 2013 ABSTRACT INTRODUCTION In developing B cells, the immunoglobulin heavy B and T lymphocytes express a large repertoire of antigen chain (IgH) locus is thought to move from repressive receptors that safeguard the robustness of our adaptive to permissive chromatin compartments to facili- immune response. Lymphocyte development uniquely tate its scheduled rearrangement. In mature B relies on scheduled genomic rearrangement of V (variable), D (diversity) and J (joining) gene segments in cells, maintenance of allelic exclusion has been the antigen receptor loci (1–3). proposed to involve recruitment of the non-product- The murine IgH locus spans nearly 3Mb, with ive IgH allele to pericentromeric heterochromatin. upstream 150 functional VH segments spread over Here, we used an allele-specific chromosome con- 2.4 Mb, followed by DH and JH segments and a 200 kb formation capture combined with sequencing constant (CH) gene region. -
Antigen-Receptor Genes & B Cell Development Learning
Katherine L. Knight, Ph.D. Host Defense 2011 Antigen-Receptor Genes and B Cell Development ANTIGEN-RECEPTOR GENES & B CELL DEVELOPMENT Date: Friday, March 18, 2011 Monday, March 21, 2011 10:30 AM – 11:30 AM 10:30 AM – 11:30 AM LEARNING GOAL You will be able to diagram and describe the stages of B cell development including somatic DNA rearrangements, and explain how a large antibody repertoire is developed. You will also be able to diagram the structure and rearrangement of T cell receptor (TCR) genes and explain how a large TCR repertoire develops. OBJECTIVES To attain the goal for these lectures you will be able to: • State the approximate size of antibody repertoire needed for immune protection. • Diagram the order of H and L chain gene rearrangements that occur during B cell development. • Describe the mechanism by which individual B cells make only one antibody (allelic exclusion) • Diagram the sequence of events leading from rearrangements of germline Ig genes to production of an Ig molecule. • Describe how antibody diversity is generated through combinatorial joining, junctional diversity, and N segment addition. • Describe how antibody diversity is generated in secondary lymphoid tissues • Describe the maturation of B cells from stem cells, including the pre-B cell receptor. • State the cell origin of CLL, Burkitt’s lymphoma, Hodgkin’s lymphoma, ALL, and multiple myeloma • Draw the structure of αβ and γδ T cell receptors. • Diagram the mechanism by which T cells express a single antigen receptor READING ASSIGNMENT Janeway’s Immunobiology (2008), Chapter 4; Chapter 7, pp 262-272; 308-312 LECTURER Katherine L. -
Collaboration of RAG2 with RAG1-Like Proteins During the Evolution of V(D)J Recombination
Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press Collaboration of RAG2 with RAG1-like proteins during the evolution of V(D)J recombination Lina Marcela Carmona,1 Sebastian D. Fugmann,2,3 and David G. Schatz1,4 1Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, 06520, USA; 2Department of Biomedical Sciences, Chang Gung University, Tao-Yuan City 33302, Taiwan; 3Chang Gung Immunology Consortium, Chang Gung Memorial Hospital, Chang Gung University, Tao-Yuan City 33302, Taiwan; 4Howard Hughes Medical Institute, New Haven, Connecticut 06511, USA The recombination-activating gene 1 (RAG1) and RAG2 proteins initiate V(D)J recombination, the process that assembles the B- and T-lymphocyte antigen receptor genes of jawed vertebrates. RAG1 and RAG2 are thought to have arisen from a transposable element, but the origins of this element are not understood. We show that two ancestral RAG1 proteins, Transib transposase and purple sea urchin RAG1-like, have a latent ability to initiate V(D)J recombination when coexpressed with RAG2 and that in vitro transposition by Transib transposase is stimulated by RAG2. Conversely, we report low levels of V(D)J recombination by RAG1 in the absence of RAG2. Recombination by RAG1 alone differs from canonical V(D)J recombination in having lost the requirement for asymmetric DNA substrates, implicating RAG2 in the origins of the “12/23 rule,” a fundamental regulatory feature of the reaction. We propose that evolution of RAG1/RAG2 began with a Transib transposon whose intrinsic recombination activity was enhanced by capture of an ancestral RAG2, allowing for the development of adaptive immunity. -
Poor Quality Vβ Recombination Signal Sequences Stochastically Enforce Tcrβ Allelic Exclusion
ARTICLE Poor quality Vβ recombination signal sequences stochastically enforce TCRβ allelic exclusion Glendon S. Wu1,2, Katherine S. Yang-Iott2, Morgann A. Klink2, Katharina E. Hayer2, Kyutae D. Lee2, and Craig H. Bassing1,2 The monoallelic expression of antigen receptor (AgR) genes, called allelic exclusion, is fundamental for highly specific immune responses to pathogens. This cardinal feature of adaptive immunity is achieved by the assembly of a functional AgR gene on one allele, with subsequent feedback inhibition of V(D)J recombination on the other allele. A range of epigenetic mechanisms have been implicated in sequential recombination of AgR alleles; however, we now demonstrate that a genetic mechanism controls this process for Tcrb. Replacement of V(D)J recombinase targets at two different mouse Vβ gene segments with a higher quality target elevates Vβ rearrangement frequency before feedback inhibition, dramatically increasing the frequency of T cells with TCRβ chains derived from both Tcrb alleles. Thus, TCRβ allelic exclusion is enforced genetically by the low quality of Vβ recombinase targets that stochastically restrict the production of two functional rearrangements before feedback inhibition silences one allele. Introduction Monoallelic expression is an essential process that limits the regulatory mechanisms, the frequent assembly of out-of-frame dosage of numerous genes. Important examples include genetic rearrangements and the requirement for AgR protein expression imprinting and X-chromosome inactivation, as well as the to drive T and B cell development dictate that biallelic expression tissue-specific allelic exclusion of olfactory neuron receptors of any TCR or Ig gene should occur in 20% of lymphocytes (Brady and lymphocyte antigen receptors (AgR). -
VEX1 Controls the Allelic Exclusion Required for Antigenic Variation in Trypanosomes
VEX1 controls the allelic exclusion required for antigenic variation in trypanosomes Lucy Glovera,1,2, Sebastian Hutchinsona,2, Sam Alsfordb, and David Horna,3 aDivision of Biological Chemistry & Drug Discovery, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom; and bDepartment of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom Edited by Paul T. Englund, The Johns Hopkins University, Baltimore, MD, and approved April 22, 2016 (received for review January 8, 2016) Allelic exclusion underpins antigenic variation and immune evasion Pol-I transcription at the active VSG-ES, combined with atten- in African trypanosomes. These bloodstream parasites use RNA uation at other VSG-ESs (17), allows trypanosomes to produce a polymerase-I (pol-I) to transcribe just one telomeric variant surface single superabundant VSG. Indeed, the active VSG generates the glycoprotein (VSG) gene at a time, producing superabundant and most abundant T. brucei mRNA and protein. The mRNA exceeds > ∼ switchable VSG coats. We identified trypanosome VSG exclusion-1 the next most abundant mRNA by 10-fold, and 10 million (VEX1) using a genetic screen for defects in telomere-exclusive ex- VSGs, constituting 10% of total cell protein (18), form a dense pression. VEX1 was sequestered by the active VSG and silencing of coat on each bloodstream-form cell (19). Antigenic variation itself other VSGs failed when VEX1 was either ectopically expressed or occurs at low frequency and without immune selection (20) due to depleted, indicating positive and negative regulation, respectively. VSG rearrangement or coordinated transcription switching from one VSG-ES to another, the latter occurring in the absence of Positive regulation affected VSGs and nontelomeric pol-I–transcribed detectable change in the DNA sequence (1). -
Chapter 5 Genetic Models
Chapter 5 1 2 Organization and Expression of Immunoglobulin Genes 3 4 5 6 Genetic Models Models to Explain Antibody Diversity 1) The Germ Line Theory : “genome posses • How to account for : the large repertoire of antibody genes to – 1) Vast diversity of antibody specificities account for all the antibody diversity” – 2) Presence of Variable regions at the amino end of Heavy and Light chains, and a 2) The Somatic Variation Theory : “genome Constant region at the carboxyl end posses a relatively small number of – 3) Existence of isotypes (different Heavy antibody genes and diversity is generated by chains) with same antigenic specificity mutation and recombination of these genes during somatic development” The two-gene model : Tonegawa (1976): Immunoglobulin gene rearrangement • Developed by Dreyer and Bennet in 1965 • Two separate genes code for the Heavy and Light chains. One codes for the V region and the other for the C region • These genes come together during at the DNA level to form a continuous message • There are thousands of V genes in germ - J Probe - Digested fragments line but only one gene for the C region 1 Three genetic loci encode immunoglobulin molecules: - Two loci encoding the light chains Multigene Families - kappa locus - lambda locus • Light Chains : V, J and C gene segments. - One locus encoding the heavy chain • Lambda : Humans (30V, 4J and 7C genes) These three loci are located on different chromosomes. • Kappa : Humans (40V, 5J and 1C genes) • Heavy Chains : V, D, J and C gene segments • Heavy Chains : Humans (50V, 25D, 6J and 8 C genes) The loci encoding immunoglobulins have a unique structure. -
Allelic Exclusion Rearrangement. III. Heavy and Light Chain Models for Antigen Receptor Gene
The Journal of Immunology Models for Antigen Receptor Gene Rearrangement. III. Heavy and Light Chain Allelic Exclusion1 Gil Kalmanovich and Ramit Mehr2 The extent of allelic exclusion in Ig genes is very high, although not absolute. Thus far, it has not been clearly established whether rapid selection of the developing B cell as soon as it has achieved the first productively rearranged, functional heavy chain is the only mechanism responsible for allelic exclusion. Our computational models of Ag receptor gene rearrangement in B lymphocytes are hereby extended to calculate the expected fractions of heavy chain allelically included newly generated B cells as a function of the probability of heavy chain pairing with the surrogate light chain, and the probability that the cell would test this pairing immediately after the first rearrangement. The expected fractions for most values of these probabilities significantly exceed the levels of allelic inclusion in peripheral B cells, implying that in most cases productive rearrangement and subsequent cell surface expression of one allele of the heavy chain gene probably leads to prevention of rearrangement completion on the other allele, and that additional mechanisms, such as peripheral selection disfavoring cells with two productively rearranged heavy chain genes, may also play a role. Furthermore, we revisit light chain allelic exclusion by utilizing the first (to our knowledge) computational model which addresses and enumerates B cells maturing with two productively rearranged light chain genes. We show that, assuming that there are no selection mechanisms responsible for abolishing cells expressing two light chains, the repertoire of newly generated B lymphocytes exiting the bone marrow must contain a significant fraction of such double-productive B cells. -
I M M U N O L O G Y Core Notes
II MM MM UU NN OO LL OO GG YY CCOORREE NNOOTTEESS MEDICAL IMMUNOLOGY 544 FALL 2011 Dr. George A. Gutman SCHOOL OF MEDICINE UNIVERSITY OF CALIFORNIA, IRVINE (Copyright) 2011 Regents of the University of California TABLE OF CONTENTS CHAPTER 1 INTRODUCTION...................................................................................... 3 CHAPTER 2 ANTIGEN/ANTIBODY INTERACTIONS ..............................................9 CHAPTER 3 ANTIBODY STRUCTURE I..................................................................17 CHAPTER 4 ANTIBODY STRUCTURE II.................................................................23 CHAPTER 5 COMPLEMENT...................................................................................... 33 CHAPTER 6 ANTIBODY GENETICS, ISOTYPES, ALLOTYPES, IDIOTYPES.....45 CHAPTER 7 CELLULAR BASIS OF ANTIBODY DIVERSITY: CLONAL SELECTION..................................................................53 CHAPTER 8 GENETIC BASIS OF ANTIBODY DIVERSITY...................................61 CHAPTER 9 IMMUNOGLOBULIN BIOSYNTHESIS ...............................................69 CHAPTER 10 BLOOD GROUPS: ABO AND Rh .........................................................77 CHAPTER 11 CELL-MEDIATED IMMUNITY AND MHC ........................................83 CHAPTER 12 CELL INTERACTIONS IN CELL MEDIATED IMMUNITY ..............91 CHAPTER 13 T-CELL/B-CELL COOPERATION IN HUMORAL IMMUNITY......105 CHAPTER 14 CELL SURFACE MARKERS OF T-CELLS, B-CELLS AND MACROPHAGES...............................................................111